Please provide your email address to receive an email when new articles are posted on . Multiple Medicare Administrative Contractors have proposed to restrict coverage for peripheral nerve block ...
The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback